Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

tRNA Activation02:26

tRNA Activation

23.1K
Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
23.1K
Regulated Protein Degradation02:58

Regulated Protein Degradation

8.9K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.9K
Acid–Base Equilibria: Activity-Based Definition of pH01:10

Acid–Base Equilibria: Activity-Based Definition of pH

1.3K
For an ideal solution, the pH is defined as the negative logarithm of the hydrogen ion concentration. For a non-ideal solution, an accurate measurement of the pH must consider the negative logarithm of the hydrogen ion activity rather than concentration. In such a solution, the pH can be more accurately defined as the negative logarithm of a product of the hydrogen ion concentration and its activity coefficient.
In solutions of very low ionic strength—for example, pure water—the...
1.3K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

8.7K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.7K
Activation Energy01:26

Activation Energy

87.1K
Activation energy is the minimum amount of energy necessary for a chemical reaction to move forward. The higher the activation energy, the slower the rate of the reaction. However, adding heat to the reaction will increase the rate, since it causes molecules to move faster and increase the likelihood that molecules will collide. The collision and breaking of bonds represents the uphill phase of a reaction and generates the transition state. The transition state is an unstable high-energy state...
87.1K
Eukaryotic Transcription Activators02:42

Eukaryotic Transcription Activators

12.9K
Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
12.9K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

STING-dependent peripheral inflammaging drives neurodegeneration via extracellular vesicles.

Cell reports·2026
Same author

Association between the use of anti-herpetic drugs and subsequent initiation of Alzheimer's disease drug treatment: Dutch population-based inception cohort study.

BMJ open·2026
Same author

Genetic Rescue of Pathogenic O-GlcNAc Dyshomeostasis Associated with Microcephaly and Motor Deficits.

eNeuro·2026
Same author

Reprogramming of bacterial virulence by lysine acetylation.

Nature communications·2026
Same author

Ubiquitination of glycogen and metabolites in cells and tissues.

Nature·2026
Same author

The Contribution of Native Protein Complexes to Targeted Protein Degradation.

ACS chemical biology·2026

関連する実験動画

Updated: Feb 12, 2026

In Vitro Analysis of E3 Ubiquitin Ligase Function
06:06

In Vitro Analysis of E3 Ubiquitin Ligase Function

Published on: May 14, 2021

6.0K

アクティビティベースのE3リガゼプロファイリングは,エステル化活性を持つE3リガゼを発見する.

Kuan-Chuan Pao1, Nicola T Wood1, Axel Knebel1

  • 1MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Dundee, UK.

Nature
|April 13, 2018
PubMed
まとめ
この要約は機械生成です。

研究者は,リシンではなく,スレオニン残基を修正する新しいタイプのE3ユビキチンリガゼ,MYCBP2を発見しました. この発見は,新しい非ライシンユビキチン化を明らかにし,真核生物におけるE3酵素の多様性に関する理解を広げている.

さらに関連する動画

Functional Characterization of RING-Type E3 Ubiquitin Ligases In Vitro and In Planta
10:27

Functional Characterization of RING-Type E3 Ubiquitin Ligases In Vitro and In Planta

Published on: December 5, 2019

9.4K
In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity
09:45

In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity

Published on: January 29, 2018

9.8K

関連する実験動画

Last Updated: Feb 12, 2026

In Vitro Analysis of E3 Ubiquitin Ligase Function
06:06

In Vitro Analysis of E3 Ubiquitin Ligase Function

Published on: May 14, 2021

6.0K
Functional Characterization of RING-Type E3 Ubiquitin Ligases In Vitro and In Planta
10:27

Functional Characterization of RING-Type E3 Ubiquitin Ligases In Vitro and In Planta

Published on: December 5, 2019

9.4K
In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity
09:45

In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity

Published on: January 29, 2018

9.8K

科学分野:

  • 生物化学
  • 分子生物学
  • 細胞生物学

背景:

  • ユビキチネーションは,細胞プロセスを調節する重要な翻訳後の変化です.
  • ユビキチン活性化酵素 (E1),ユビキチン結合酵素 (E2) とユビキチン結合酵素 (E3s) がユビキチン化を媒介する.
  • E3リガスはRING,HECT,RBRタイプに分類され,主にライシン残基を改変する.

研究 の 目的:

  • リスン改変を超えた新しいE3リガースの活性性を特定する.
  • MYCBP2 (PHR1) のメカニズムと基板特異性を記述する.
  • 高級ユカリオットにおける非ライシンユビキチネーションの影響を調査する.

主な方法:

  • HECTとRBRのようなE3リガゼの活性に基づくタンパク質プロファイリング.
  • 基質の特異性を決定する生化学的測定
  • MYCBP2 E3リガゼの結晶学的な特徴づけ

主要な成果:

  • MYCBP2は,エステル化活性を持つ新しいE3リガゼとして特定されました.
  • MYCBP2はセリンの残留物に対する固有の選択性を示す.
  • RING-Cys-relay (RCR) と呼ばれる新しいE3リガゼは,チオエステル中間物質を使用しています.

結論:

  • MYCBP2は,ライシン以外のユビキチネーション活性を持つE3リガゼ (RCR) のユニークなクラスです.
  • MYCBP2によるスレオニンのユビキチン化は細胞の調節に作用する.
  • E3酵素は,これまで理解していたよりも,より大きなメカニズム的多様性を持っています.